J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bjerketorp, J.
Right arrow Articles by Frykberg, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bjerketorp, J.
Right arrow Articles by Frykberg, L.
Agricola
Right arrow Articles by Bjerketorp, J.
Right arrow Articles by Frykberg, L.
J Med Microbiol 53 (2004), 945-951; DOI: 10.1099/jmm.0.45638-0
© 2004 Society for General Microbiology
ISSN 0022-2615

Sorting a Staphylococcus aureus phage display library against ex vivo biomaterial

Joakim Bjerketorp, Anna Rosander, Martin Nilsson, Karin Jacobsson and Lars Frykberg

Department of Microbiology, Swedish University of Agricultural Sciences, SE-750 07 Uppsala, Sweden

Correspondence Lars Frykberg lars.frykberg{at}mikrob.slu.se

Received February 18, 2004
Accepted June 25, 2004

A phage display library made from Staphylococcus aureus DNA was sorted against a central venous catheter (CVC) that had been removed from a patient 2 days after insertion. After the first panning, approximately 50 % of the clones encoded proteins known to interact with mammalian proteins. After the second and third pannings, fibrinogen-binding and ß2-glycoprotein I (ß2-GPI)-binding phage particles were clearly dominating. Proteins adsorbed to different CVCs were investigated using specific antibodies. Among the proteins probed for, fibrinogen was most abundant, but, interestingly, ß2-GPI was also detected on all tested CVCs.


Abbreviations: CF, clumping factor; CVC, central venous catheter; Fg, fibrinogen; Fn, fibronectin; ß2-GPI, ß2-glycoprotein I.


    INTRODUCTION
 TOP
 INTRODUCTION
 METHODS
 RESULTS AND DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
Biomaterial is widely used in modern medicine, both as a permanent replacement, e.g. prosthetic heart valves, and for short time usage, e.g. intravenous catheters. In contact with blood, a number of different plasma proteins adhere to the implanted material. Protein adsorption can cause problems such as activation of the coagulation system, complement activation and promotion of bacterial colonization (Courtney et al., 1994). The adsorption depends on the material itself, but is also a dynamic process, thus the composition of adsorbed proteins may change over time (Vroman et al., 1980). Skin-associated Staphylococcus epidermidis and Staphylococcus aureus are among the bacteria most frequently isolated from biomaterial infections (von Eiff et al., 2002).

S. aureus encodes a large number of proteins that interact with host proteins, so-called receptins (Kronvall & Jönsson, 1999). Many are well characterized, but additional receptins have been predicted from the genome sequence (Kuroda et al., 2001). Several plasma proteins promote S. aureus adherence to polymeric surfaces, i.e. fibrinogen (Fg), fibronectin (Fn), laminin, vitronectin, thrombospondin and von Willebrand factor (vWf) (Herrmann et al., 1988, 1991, 1997; Vaudaux et al., 1984; Fuquay et al., 1986). Studies of S. aureus adherence to biomaterial coated with various plasma proteins have given valuable information on the host proteins with which S. aureus interacts. However, information on which receptin(s) mediates the adherence is limited since S. aureus encodes several receptins with similar binding specificity. In addition, such studies depend on the bacterial growth conditions and growth phase and may not totally reflect the in vivo situation.

Since its introduction by Smith in 1985 (Smith, 1985), phage display has been a very useful method for identifying protein–protein interactions. A foreign protein is displayed at the phage surface as a fusion to one of the phage coat proteins. Usually the minor (pIII) or major (pVIII) coat protein is used for this purpose. To minimize disturbance of phage functions, systems that allow fusion to only some of the coat proteins, e.g. phagemid vectors, are frequently used. Insertion of foreign DNA into gene-VIII-based phagemid vectors results in multivalent display, but the number of displayed polypeptides will vary considerably for different polypeptides (Malik et al., 1996, and references therein). Phage libraries made from bacterial DNA consist of phage particles that together theoretically display all proteins encoded by the bacterial genome. Simultaneously, the genetic information for the displayed polypeptide is contained in the phagemid vector inside the phage particle. Such libraries can be used for identification of receptins by panning against various ligands (Jacobsson & Frykberg, 1995, 1996, 1998). Here, we have sorted an S. aureus library against a central venous catheter (CVC) removed from a patient 2 days after insertion.


    METHODS
 TOP
 INTRODUCTION
 METHODS
 RESULTS AND DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
Biomaterials.

Discarded polyurethane CVCs (Becton Dickinson) were obtained from Uppsala University Hospital, Sweden. The CVCs had been removed from five different patients who had had a CVC inserted in a major blood vessel for periods varying between 2 and 18 days. The CVCs were frozen, and before use, gently washed in PBST (PBS + 0.05 % Tween 20) to remove any blood remnants.

Phage library.

The library used is described by Bjerketorp et al. (2002). It was constructed from genomic DNA of S. aureus strain Newman, consisted of 1 x 107 clones and had a titre of 1.5 x 109 c.f.u. ml–1. The library was made in the gene-VIII-based phagemid vector pG8SAET (Jacobsson & Frykberg, 2001), which should result in multivalent display of the foreign polypeptides on the phage surface. The vector contains a screening tag (E-tag) in reading frame with gene VIII but out-of-frame with the signal peptide. The cloning site is located just in front of the E-tag and hence the expression can be restored if an inserted DNA fragment, with an open reading frame, corrects the frameshift. Expression of the E-tag is used to follow enrichment for putative correct clones.

Escherichia coli strain TG1 was grown in Luria–Bertani (LB) broth or on LA plates (LB broth supplemented with 1.5 % agar). Ampicillin (50 µg ml–1) was added when appropriate (LA-Amp). All bacterial incubations were done at 37 °C.

Pannings.

A 400 µl portion of the phagemid library was mixed with casein (Sigma) at a final concentration of 100 µg ml–1 and incubated with a ~5-mm-long piece of CVC removed from a patient 2 days after insertion. After panning at room temperature (RT) with shaking for 4 h, the CVC was washed thoroughly with PBST and bound phages were eluted with 400 µl elution buffer (0.05 M sodium citrate, 0.15 M NaCl, pH 2.0). The eluate was neutralized with 50 µl 2 M Tris-buffer, pH 8.7, and 0.1–50 µl was added to 25 µl stationary phase E. coli TG1, together with LB broth to a final volume of 200 µl. The infection proceeded for 20–30 min at RT before the suspension was spread on LA-Amp plates. The resulting colonies were screened (see below) and infected with helper phage R408 (Promega) for production of enriched phage stocks for repanning, as described by Jacobsson et al. (2003). Repannings were carried out as described above, but for only 2 h.

Panning against in vitro coated microwells (Maxisorp; Nunc) was done as described by Jacobsson & Frykberg (1998). Wells were coated for 1 h with human plasma (Uppsala University Hospital, Sweden) diluted 20 times in coating buffer (50 mM NaHCO3, pH 9).

Individual phage stocks were prepared by R408 infection of bacterial cultures of clones Nbm21, Nbm29 and Nbm69 (Table 1). The titre of each phagemid stock was adjusted to 108 c.f.u. ml–1. Pannings with these phage stocks against ~5 mm pieces of CVCs (either unused, or removed from patients after 6, 9, 13 or 18 days) or against pure ligands in microwells were performed essentially as described above. Human Fg was obtained from IMCO and human IgG was purchased from Kabi Vitrum. Recombinant human vWf (rvWf) was a kind gift from Dr Å. Ljungh, Lund, Sweden (originally from Professor F. Dorner, Vienna). The rvWf has been shown to have an activity comparable to human plasma-derived vWf (Fischer et al., 1997). ß2-Glycoprotein I (GPI) was acquired from ICN (sold under the alternative name apolipoprotein H). Fg, IgG, rvWf or ß2-GPI were coated in microwells, at a concentration of 5 µg ml–1, in order to establish the binding capacity of the individual phage stocks.


View this table:
[in this window]
[in a new window]
 
Table 1. Different clones found after sorting an S. aureus genomic phage display library against an ex vivo CVC
 

Screening and sequencing of phagemid clones.

After each round of panning, colonies were transferred to nitrocellulose membranes (Schleicher & Schuell) and subsequently screened for expression of the E-tag with anti-E-tag antibodies (Amersham Biosciences) as described by Jacobsson et al. (2003). Phagemid DNA from E-tag-positive clones was prepared with the Qiagen Miniprep kit according to the manufacturer's instructions. The inserted DNA fragments were sequenced using the DYEnamic ET Terminator Cycle Sequencing Premix kit (Amersham Biosciences) and the samples were analysed using the ABI 377 DNA Sequencer (Perkin Elmer) according to the manufacturer's instructions. The Vector NTI computer software (Informax) was used for handling of the sequences obtained.

Analysis of proteins adsorbed to the ex vivo biomaterials.

Pieces of CVCs (~5 mm) were boiled in 40 µl sample buffer (62.5 mM Tris/HCl, pH 6.8; 10 % glycerol; 2 % SDS; 5 % ß-mercaptoethanol; and 0.01 % bromophenol blue) for 5 min and the released proteins were subjected to SDS-PAGE using the PhastSystem with 4–15 % gels (Amersham Biosciences). For analysis of ß2-GPI, pieces of the same CVCs were boiled in a non-reducing buffer (composition as above, but without the ß-mercaptoethanol), since this protein contains 11 disulfide bridges (Kato & Enjyoji, 1991), and the monoclonal antibodies only reacted weakly with the reduced form (unpublished observation). Proteins were diffusion blotted (PhastSystem at 65 °C for 40 min) onto nitrocellulose membranes (ECL; Amersham Biosciences), which were treated with the Quentix Western Blot Signal Enhancer kit (Pierce). Thereafter the membranes were blocked for 30 min in PBST containing casein at a concentration of 1 mg ml–1. Proteins were detected using horseradish peroxidase (HRP)-labelled antibodies against Fn (DakoCytomation), Fg (DakoCytomation) or IgG (ICN). ß2-GPI was detected using an anti-ß2-GPI monoclonal antibody (Chemicon) followed by HRP-labelled anti-mouse antibodies (Amersham Biosciences). Bound HRP-labelled antibodies were visualized using BM Blue POD substrate (Roche).


    RESULTS AND DISCUSSION
 TOP
 INTRODUCTION
 METHODS
 RESULTS AND DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
Sorting the phage library against ex vivo biomaterial

The S. aureus phage display library was panned in three consecutive cycles against a CVC that had been removed from a patient 2 days after implantation. The phage display approach does not discriminate between cell-wall-located and secreted receptins, and is independent of the expression level of the receptin. Thus in theory all bacterial proteins interacting with the biomaterial may be found. After each panning, colonies were counted and screened for E-tag expression. In the first panning, 9 x 102 phagemid particles ml–1 were recovered, and in the second and third pannings the number of phagemid particles was 4 x 103 and 6 x 104 ml–1, respectively. The frequency of E-tag-positive clones increased from 12 to 38 and to 78 % in the consecutive pannings, showing that an enrichment for clones with open reading frames occurred.

From each panning, approximately 50 E-tag-positive clones were isolated and the DNA sequences of the inserts were determined. Clones were considered to represent an authentic interaction if overlapping inserts of a gene were found in two or more clones, or if a clone encoded a known receptin. After the first panning, approximately 50 % of the clones were correct. In the second and third pannings, only one background clone was found. However, despite the large number of clones investigated, no novel receptin was identified.

Receptins identified

The receptins identified were: coagulase (Coa), an Fg- and prothrombin (PT)-binding protein with the ability to coagulate plasma; protein A, an IgG- and vWf-binding protein; Efb, a Fg-binding protein; FnbpA/B, two similar Fn- and Fg-binding proteins; and Sbi, an IgG- and ß2-GPI-binding protein (Table 1). The binding domains in these proteins have been mapped, and therefore it is possible to deduce which binding property is displayed by a selected phage particle. However, it is possible that additional, so far unidentified, binding domains may exist or that a domain might bind more than one protein. The majority of isolated phage encoded either Fg-binding or ß2-GPI-binding polypeptides. Part of the coa gene was found in 35 clones, all encoding the Fg-binding repeat region, and only in one clone was the PT-binding domain also present. Altogether, 74 clones contained parts of the sbi gene. Interestingly, 51 of these clones encoded only the part known to bind ß2-GPI, while the others encoded polypeptides with the ability to bind both IgG and ß2-GPI.

Protein Sbi contains a signal peptide and has been found associated with the surface of S. aureus. However, the protein does not contain the typical LPXTG motif and the transmembrane domain found in most cell-wall-bound proteins, suggesting a different type of association to the surface. Still, similar to cell-wall-spanning domains, Sbi contains a repetitive domain with proline residues repeated every fifth amino acid (Zhang et al., 1998, 1999).

Panning against microwells coated in vitro with plasma

The results from the panning experiments against ex vivo biomaterials suggest that ß2-GPI is easily accessible for Sbi displayed on the phage surface. One possible explanation for this could be that ß2-GPI is deposited later than Fg and Fn. As a comparison, plasma proteins were coated onto microwells for 1 h, and the phage display library was panned in two cycles against the wells. Following the first and second pannings, 24 E-tag-positive clones were analysed. After the first panning, nine clones contained the coa gene, five the fnbB gene, three the spa gene (encoding protein A) and one the efb gene, while six clones were considered as background. After the second panning, only clones encoding Fg-binding proteins were found. These results suggest that Fg is the main protein recognized by S. aureus proteins after a short in vitro coating.

Proteins released from ex vivo biomaterials

The high number of clones with ß2-GPI-binding capacity suggests that either ß2-GPI is a major component on ex vivo biomaterial, or it is more accessible than other adsorbed proteins. Proteins were released from CVCs removed from patients after different implantation periods and analysed by SDS-PAGE and Western blotting. Due to the limited amount of ex vivo CVC material available, the CVC removed after 2 days was not included in this experiment. To detect relevant proteins, antibodies specific for Fg, Fn, IgG and ß2-GPI were used. Fg was the major component released from all CVCs (Fig. 1b), but Fn was also detected in all samples (data not shown). IgG was detected in some of the samples, and relatively weak signals were obtained (Fig. 1c). Interestingly, ß2-GPI was detected in all samples, although the signal was weaker than for Fg (Fig. 1e). However, the signal strength in a Western blot is semi-quantitative and depends on a number of different factors besides the amount of protein, e.g. the quality of the antibodies used, the ability of the antibodies to recognize the target protein in a denatured state, as well as the efficiency with which the protein is transferred to the nitrocellulose membrane.



View larger version (41K):
[in this window]
[in a new window]
 
Fig. 1. Analysis of proteins released from ex vivo biomaterial. Coomassie brilliant blue stained SDS-PAGE gels run under reducing (a) and non-reducing conditions (d), and Western blots of the corresponding gels incubated with antibodies against human Fg (b), IgG (c) and ß2-GPI (e). Lanes: 1, proteins from a CVC removed after 6 days; 2, after 9 days; 3, after 13 days; 4, after 18 days. M, Molecular mass standard (Bio-Rad broad range: 200, 116, 97, 66, 45, 31, 22, 14 and 7 kDa).

 

To our knowledge it has not previously been shown that ß2-GPI is deposited on biomaterial. ß2-GPI is a single-chain 50 kDa protein, and although present in relatively high amounts in serum (~0.2 mg ml–1), the biological function of ß2-GPI is not completely clear. It binds to negatively charged substances such as heparin and phospholipids, and is structurally related to regulators of the complement system (Kato & Enjyoji, 1991; Steinkasserer et al., 1991). ß2-GPI has been reported to have several biological functions, such as promoting clearance of liposomes and maybe foreign particles from the circulation, but also effects on the coagulation system have been reported (Chonn et al., 1995; Nimpf et al., 1986). The mechanism for the anticoagulating activity of ß2-GPI was suggested in a recent publication, which showed that ß2-GPI binds to factor XI and inhibits its activation (Shi et al., 2004).

Panning with phage stocks against ex vivo biomaterials and pure proteins

Considering bacterial adhesion to biomaterial, the total amount of protein deposited is less important than its accessibility on the surface. To confirm the accessibility of Fg, IgG and ß2-GPI on different CVCs, phage stocks were made from three relevant clones. After adjusting their titres, the binding to CVCs as well as to pure proteins immobilized in microwells was investigated. Although CVCs were derived from different individuals and the insertion time varied, this did not seem to greatly affect the ability of the phage clones to bind to the CVCs. As expected from the Western blot data, the Fg-binding clone Nbm69 demonstrated good binding to all CVCs, but ~100 times more phage particles bound to pure Fg (Fig. 2a). The binding capacity of Nbm29, encoding part of protein A, varied to some extent between CVCs, but it was much higher than to an uncoated CVC (Fig. 2b). The phage particles also bound to pure IgG, but no binding to rvWf was observed (Fig. 2b). The lack of binding to rvWf may be caused by differences between rvWf and vWf purified from serum; alternatively, the conditions in our experiments might not be ideal to detect this interaction. The sbi-derived Nbm21 phage bound well to ß2-GPI but, as expected, not to pure IgG (Fig. 2c). Interestingly, these phage particles also bound well to all tested CVCs (Fig. 2c), showing that ß2-GPI is accessible on all tested CVC surfaces, further strengthening our findings regarding ß2-GPI in the Western blot (Fig. 1e). A negative control phage stock containing the vector pG8SAET showed no binding to either of the CVCs (data not shown).



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2. Panning of phage stocks against CVCs removed from patients after a different number of days (white bars) and against microwells coated in vitro with pure human proteins as indicated (black bars). (a) Clone Nbm69 displaying part of the Fg-binding protein Coa; (b) Nbm29 displaying part of protein A reported to bind IgG and vWf; (c) Nbm21 displaying the ß2-GPI-binding region of protein Sbi. None of the phage stocks bound to casein (data not shown).

 

Even though the signal strengths in the Western blots of proteins released from the CVCs may not show the exact relation between protein amounts, the signals imply that Fg is present in higher amounts than ß2-GPI (Fig. 1). However, the Fg-binding and ß2-GPI-binding phage particles bound to the CVCs in comparable numbers (Fig. 2), thus demonstrating that it is the surface accessibility rather than the total amount of protein that is of importance for the phage binding. The binding of phage particles to pure Fg was approximately 25 times higher than to pure ß2-GPI, and since similar numbers of Nbm69 and Nbm21 phage particles bound to the CVCs, this suggests that ß2-GPI is actually more accessible than Fg on the CVCs.

Concluding remarks

When Dickinson et al. (1995) investigated the adherence of S. aureus to in vitro coated glass surfaces under flow, it was concluded that adherence to Fg or plasma almost exclusively depended on the Fg-binding protein clumping factor (CF). Francois et al. (2000) also demonstrated the importance of CF for S. aureus binding to Fg-coated polyvinyl chloride (PVC) tubing. However, it was also demonstrated that Fg deposited on the PVC tubing in vitro was much more efficient in promoting S. aureus adherence than the Fg deposited during haemodialysis. In addition, an S. aureus mutant lacking the CF bound in 10-fold higher numbers to the tubing coated during haemodialysis than to control tubing coated with albumin. Similarly, our result from panning against a well coated with plasma in vitro yielded mainly Fg-binding phage. A possible explanation for these differences is the over layering of initially adhered Fg by other plasma proteins on the haemodialysis tubing. When the tubing coated during dialysis was subjected to analysis of the protein content, it was suggested that an unidentified protein(s) different from Fg, vitronectin, thrombospondin and vWf was responsible for the additional binding of S. aureus to the tubing (Francois et al., 2000). Our panning against the CVCs removed from different patients shows that ß2-GPI is an easily accessible component, and may be the unidentified target on the haemodialysis tubing above. Thus the ability to bind ß2-GPI could be one mechanism by which S. aureus adheres to biomaterial.

ß2-GPI has attracted a lot of attention in recent years due to its involvement in autoimmune disease. In antiphospholipid syndrome (APS), autoantibodies are often not directed against phospholipids alone, but against phospholipids bound to ß2-GPI or to ß2-GPI only (McNeil et al., 1990; Galli et al., 1990). Although the exact specificity of antiphospholipids (aPL) antibodies is under debate, it has been suggested that the concept ‘aPL antibodies’ needs to be revaluated since the major target is presumably not phospholipids but ß2-GPI (Li & Krilis, 2003). The cause for the appearance of these autoantibodies is not known, but aPL antibodies are frequently found in conjunction with various infections (McNeil et al., 1991). It has been suggested that a change in conformation of ß2-GPI upon contact with negatively charged phospholipids or surfaces may be responsible for exposure of autoepitopes (Borchman et al., 1995; Chamley et al., 1999; Wang et al., 2000). In this context, the binding of ß2-GPI to biomaterial is interesting. It is known that binding of plasma proteins to polymer surfaces can result in a conformational change of the protein (Barbucci & Magnani, 1994). Perhaps as a consequence, haemodialysis patients were found to have a significantly higher incidence of aPL antibodies compared to control groups (Fabrizi et al., 1999; McIntyre & Wagenknecht, 2003). The finding of ß2-GPI on the surface of CVCs is intriguing, but whether adherence of ß2-GPI to biomaterials is a general phenomenon needs to be investigated.

Sorting an S. aureus phage display library against ex vivo biomaterials revealed several possible interactions. However, this type of experiment identifies proteins that bind to the target regardless of the normal localization and function of the protein. Thus it may be possible to find interactions without biological meaning. Still, all receptins identified in this study contain a signal peptide and are extracellular proteins, thus they could be of biological significance. Two of them, Efb and Coa, are secreted, although a small fraction of Coa seems to be surface associated (Bodén & Flock, 1989; McDevitt et al., 1992). Their primary function probably is not adherence; still the binding of these proteins to biomaterial might serve other biological functions. After the initial adherence of S. aureus to biomaterial, it is conceivable that the Fg binding of Coa could cause a localized coagulation, which could promote biofilm formation on the biomaterial. Interestingly, Efb and Coa were also found when an S. aureus library was sorted against platelets, suggesting that these proteins bind platelets via Fg as a bridging molecule and possibly could aid S. aureus adherence to platelets (Heilmann et al., 2002).

The importance of CF for S. aureus adherence to Fg has been demonstrated in several publications (e.g. Dickinson et al., 1995; Francois et al., 2000), but CF was not found in this study. Most likely, phages that display CF are out-competed by other binding phages, perhaps due to its large ligand-binding domain. Although the major selection should be for binding to the immobilized ligands, other factors may also influence which phage dominate after panning. For example, it is possible that different phagemid clones replicate to different numbers, or that different polypeptides, with the same binding specificity, might be displayed with different efficiency. Ten different clones encoding parts of the coa gene were found after the first and second pannings. Among these, Nbm42 contains almost five complete Fg-binding repeats, but this clone is not found after the second or third pannings. Instead, Nbm69, encoding only two Fg-binding repeats, dominates after the third panning. Clearly factors other than Fg-binding alone are responsible for the dominance of this clone.

Although no new receptin was identified in this study, it was shown that ß2-GPI is deposited on the CVCs. The results also showed that with this kind of phage library, only one panning cycle is needed to obtain a high frequency of correct clones. Further pannings resulted in an even higher frequency of correct clones, but much fewer unique clones. Thus in order to find new interactions, it might be better to make only one panning and investigate a larger number of clones.


    ACKNOWLEDGEMENTS
 TOP
 INTRODUCTION
 METHODS
 RESULTS AND DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
We express our gratitude to the personnel at the hospital wards NIVA and NIMA, Uppsala University Hospital, Sweden, who collected the biomaterial. This work was supported by the Swedish Foundation for Strategic Research, Infection & Vaccinology Research Program, grant 24/98 and Biostapro AB.


    REFERENCES
 TOP
 INTRODUCTION
 METHODS
 RESULTS AND DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 

  • Barbucci, R. & Magnani, A. (1994). Conformation of human plasma proteins at polymer surfaces: the effectiveness of surface heparinization. Biomaterials 15, 955–962.[CrossRef][Medline]

  • Bjerketorp, J., Nilsson, M., Ljungh, Å., Flock, J. I., Jacobsson, K. & Frykberg, L. (2002). A novel von Willebrand-binding protein expressed by Staphylococcus aureus. Microbiology 148, 2037–2044.[Abstract/Free Full Text]

  • Bodén, M. K. & Flock, J. I. (1989). Fibrinogen-binding protein/clumping factor from Staphylococcus aureus. Infect Immun 57, 2358–2363.[Abstract/Free Full Text]

  • Bodén, M. K. & Flock, J. I. (1994). Cloning and characterization of a gene for a 19 kDa fibrinogen-binding protein from Staphylococcus aureus. Mol Microbiol 4, 599–606.

  • Borchman, D., Harris, E. N., Pierangeli, S. S. & Lamba, O. P. (1995). Interactions and molecular structure of cardiolipin and beta 2-glycoprotein 1 (beta 2-GP1). Clin Exp Immunol 102, 373–378.[Medline]

  • Chamley, L. W., Duncalf, A. M., Konarkovska, B., Mitchell, M. D. & Johnson, P. M. (1999). Conformationally altered ß2-glycoprotein I is the antigen for anti-cardiolipin autoantibodies. Clin Exp Immunol 155, 571–576.[CrossRef][Medline]

  • Chonn, A., Semple, S. C. & Cullis, P. R. (1995). Beta 2-glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of ‘‘non-self’’ particles. J Biol Chem 270, 25845–25849.[Abstract/Free Full Text]

  • Courtney, J. M., Lamba, N. M., Sundaram, S. & Forbes, C. D. (1994). Biomaterials for blood-contacting applications. Biomaterials 15, 737–744.[CrossRef][Medline]

  • Dickinson, R. B., Nagel, J. A., McDevitt, D., Foster, T. J., Proctor, R. A. & Cooper, S. L. (1995). Quantitative comparison of clumping factor- and coagulase-mediated Staphylococcus aureus adhesion to surface-bound fibrinogen under flow. Infect Immun 63, 3143–3150.[Abstract]

  • Fabrizi, F., Sangiorgio, R., Pontoriero, G., Corti, M., Tentori, F., Troina, E. & Locatelli, F. (1999). Antiphospholipid (aPL) antibodies in end-stage renal disease. J Nephrol 12, 89–94.[Medline]

  • Fischer, B. E., Schlokat, U., Reiter, M., Mundt, W. & Dorner, F. (1997). Biochemical and functional characterization of recombinant von Willebrand factor produced on a large scale. Cell Mol Life Sci 53, 943–950.[CrossRef][Medline]

  • Francois, P., Schrenzel, J., Stoerman-Chopard, C., Favre, H., Herrmann, M., Foster, T. J., Lew, D. P. & Vaudaux, P. (2000). Identification of plasma proteins adsorbed on hemodialysis tubing that promote Staphylococcus aureus adhesion. J Lab Clin Med 135, 32–42.[CrossRef][Medline]

  • Fuquay, J. I., Loo, D. T. & Barnes, D. W. (1986). Binding of Staphylococcus aureus by human serum spreading factor in an in vitro assay. Infect Immun 52, 714–717.[Abstract/Free Full Text]

  • Galli, M., Comfurius, P., Maassen, C., Hemker, H. C., de Baets, M. H., van Breda-Vriesman, P. J., Barbui, T., Zwaal, R. F. & Bevers, E. M. (1990). Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335, 1544–1547.[CrossRef][Medline]

  • Hartleib, J., Kohler, N., Dickinson, R. B. & 7 other authors (2000). Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. Blood 96, 2149–2156.[Abstract/Free Full Text]

  • Heilmann, C., Herrmann, M., Kehrel, B. E. & Peters, G. (2002). Platelet-binding domains in 2 fibrinogen-binding proteins of Staphylococcus aureus identified by phage display. J Infect Dis 186, 32–39.[CrossRef][Medline]

  • Herrmann, M., Vaudaux, P. E., Pittet, D., Auckenthaler, R., Lew, P. D., Schumacher-Perdreau, F., Peters, G. & Waldvogel, F. A. (1988). Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 158, 693–701.[Medline]

  • Herrmann, M., Suchard, S. J., Boxer, L. A., Waldvogel, F. A. & Lew, P. D. (1991). Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun 59, 279–288.[Abstract/Free Full Text]

  • Herrmann, M., Hartleib, J., Kehrel, B., Montgomery, R. R., Sixma, J. J. & Peters, G. (1997). Interaction of von Willebrand factor with Staphylococcus aureus. J Infect Dis 176, 984–991.[Medline]

  • Jacobsson, K. & Frykberg, L. (1995). Cloning of ligand-binding domains of bacterial receptors by phage display. Biotechniques 18, 878–885.[Medline]

  • Jacobsson, K. & Frykberg, L. (1996). Phage display shot-gun cloning of ligand-binding domains of prokaryotic receptors approaches 100 % correct clones. Biotechniques 20, 1070–1081.[Medline]

  • Jacobsson, K. & Frykberg, L. (1998). Gene VIII-based, phage-display vectors for selection against complex mixtures of ligands. Biotechniques 24, 294–301.[Medline]

  • Jacobsson, K. & Frykberg, L. (2001). Shotgun phage display cloning. Comb Chem High Throughput Screen 4, 135–143.[Medline]

  • Jacobsson, K., Rosander, A., Bjerketorp, J. & Frykberg, L. (2003). Shotgun Phage Display – selection for bacterial receptins or other exported proteins. Biol Proced Online 5, 123–135.[CrossRef][Medline]

  • Jönsson, K., Signäs, C., Müller, H. P. & Lindberg, M. (1991). Two different genes encode fibronectin binding proteins in Staphylococcus aureus.The complete nucleotide sequence and characterization of the second gene. Eur J Biochem 202, 1041–1048.[Medline]

  • Kaida, S., Miyata, T., Yoshizawa, Y., Kawabata, S., Morita, T., Igarashi, H. & Iwanaga, S. (1987). Nucleotide sequence of the staphylocoagulase gene: its unique COOH-terminal 8 tandem repeats. J Biochem (Tokyo) 102, 1177–1186.[Abstract/Free Full Text]

  • Kato, H. & Enjyoji, K. (1991). Amino acid sequence and location of the disulfide bonds in bovine beta 2-glycoprotein I: the presence of five Sushi domains. Biochemistry 30, 11687–11694.[CrossRef][Medline]

  • Kawabata, S., Morita, T., Miyata, T., Iwanaga, S. & Igarashi, H. (1986). Isolation and characterization of staphylocoagulase chymotryptic fragment.Localization of the procoagulant- and prothrombin-binding domain of this protein. J Biol Chem 261, 1427–1433.[Abstract/Free Full Text]

  • Kronvall, G. & Jönsson, K. (1999). Receptins: a novel term for an expanding spectrum of natural and engineered microbial proteins with binding properties for mammalian proteins. J Mol Recognit 12, 38–44.[CrossRef][Medline]

  • Kuroda, M., Ohta, T., Uchiyama, I. & 34 other authors (2001). Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357, 1225–1240.[CrossRef][Medline]

  • Li, Z. & Krilis, S. A. (2003). Anti-ß2-glycoprotein I antibodies and the antiphospholipid syndrome. Autoimmun Rev 2, 229–234.[CrossRef][Medline]

  • Malik, P., Terry, T. D., Gowda, L. R., Langara, A., Petukhov, S. A., Symmons, M. F., Welsh, L. C., Marvin, D. A. & Perham, R. N. (1996). Role of capsid structure and membrane protein processing in determining the size and copy number of peptides displayed on the major coat protein of filamentous bacteriophage. J Mol Biol 260, 9–21.[CrossRef][Medline]

  • McDevitt, D., Vaudaux, P. & Foster, T. J. (1992). Genetic evidence that bound coagulase of Staphylococcus aureus is not clumping factor. Infect Immun 60, 1514–1523.[Abstract/Free Full Text]

  • McIntyre, J. A. & Wagenknecht, D. R. (2003). Antiphospholipid antibodies and renal transplantation: a risk assessment. Lupus 12, 555–559.[Abstract/Free Full Text]

  • McNeil, H. P., Simpson, R. J., Chesterman, C. N. & Krilis, S. A. (1990). Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 87, 4120–4124.[Abstract/Free Full Text]

  • McNeil, H. P., Chesterman, C. N. & Krilis, S. A. (1991). Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 49, 193–280.[Medline]

  • Nimpf, J., Bevers, E. M., Bomans, P. H., Till, U., Wurm, H., Kostner, G. M. & Zwaal, R. F. (1986). Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein I. Biochim Biophys Acta 884, 142–149.[Medline]

  • Shi, T., Iverson, G. M., Qi, J. C., Cockerill, K. A., Linnik, M. D., Konecny, P. & Krilis, S. A. (2004). ß2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I. Proc Natl Acad Sci U S A 101, 3939–3944.[Abstract/Free Full Text]

  • Signäs, C., Raucci, G., Jönsson, K., Lindgren, P. E., Anantharamaiah, G. M., Höök, M. & Lindberg, M. (1989). Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides. Proc Natl Acad Sci U S A 86, 699–703.[Abstract/Free Full Text]

  • Smith, G. P. (1985). Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228, 1315–1317.[Abstract/Free Full Text]

  • Steinkasserer, A., Estaller, C., Weiss, E. H., Sim, R. B. & Day, A. J. (1991). Complete nucleotide and deduced amino acid sequence of human beta 2-glycoprotein I. Biochem J 277, 387–391.

  • Uhlen, M., Guss, B., Nilsson, B., Gatenbeck, S., Philipson, L. & Lindberg, M. (1984). Complete sequence of the staphylococcal gene encoding protein A.A gene evolved through multiple duplications. J Biol Chem 259, 1695–1702.[Abstract/Free Full Text]

  • Vaudaux, P., Suzuki, R., Waldvogel, F. A., Morgenthaler, J. J. & Nydegger, U. E. (1984). Foreign body infection: role of fibronectin as a ligand for the adherence of Staphylococcus aureus. J Infect Dis 150, 546–553.[Medline]

  • von Eiff, C., Peters, G. & Heilmann, C. (2002). Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2, 677–685.[CrossRef][Medline]

  • Vroman, L., Adams, A. L., Fischer, G. C. & Munoz, P. C. (1980). Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Blood 55, 156–159.[Abstract/Free Full Text]

  • Wang, S. X., Sun, Y. T. & Sui, S. F. (2000). Membrane-induced conformational change in human apolipoprotein H. Biochem J 348, 103–106.

  • Wann, E. R., Gurusiddappa, S. & Höök, M. (2000). The fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen. J Biol Chem 275, 13863–13871.[Abstract/Free Full Text]

  • Zhang, L., Jacobsson, K., Vasi, J., Lindberg, M. & Frykberg, L. (1998). A second IgG-binding protein in Staphylococcus aureus strain 8325-4. Microbiology 144, 985–991.[Abstract/Free Full Text]

  • Zhang, L., Jacobsson, K., Ström, K., Lindberg, M. & Frykberg, L. (1999). Staphylococcus aureus expresses a cell surface protein that binds both IgG and ß2-glycoprotein I. Microbiology 145, 177–183.[Abstract/Free Full Text]





    This Article
    Right arrow Abstract Freely available
    Right arrow Full Text (PDF)
    Right arrow Alert me when this article is cited
    Right arrow Alert me if a correction is posted
    Right arrow Citation Map
    Services
    Right arrow Email this article to a friend
    Right arrow Similar articles in this journal
    Right arrow Similar articles in PubMed
    Right arrow Alert me to new issues of the journal
    Right arrow Download to citation manager
    Right arrow reprints & permissions
    Citing Articles
    Right arrow Citing Articles via CrossRef
    Right arrow Citing Articles via Google Scholar
    Google Scholar
    Right arrow Articles by Bjerketorp, J.
    Right arrow Articles by Frykberg, L.
    Right arrow Search for Related Content
    PubMed
    Right arrow PubMed Citation
    Right arrow Articles by Bjerketorp, J.
    Right arrow Articles by Frykberg, L.
    Agricola
    Right arrow Articles by Bjerketorp, J.
    Right arrow Articles by Frykberg, L.


    HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
    INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS